Molluscum contagiosum: The need for physician intervention and new treatment options

Cutis

Volumn 73, Issue 3, 2004, Pages 202-206

  Bikowski Jr , Joseph B ^a  

^a Bikowski Skin Care Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANTHARIDIN; IMIQUIMOD; IMMUNOMODULATING AGENT; POTASSIUM HYDROXIDE; RETINOIC ACID;

ARTICLE; CRYOSURGERY; CURETTAGE; ELECTROSURGERY; HEALTH CARE NEED; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE SYSTEM; IMMUNOMODULATION; INFECTION RISK; INOCULATION; MOLLUSCUM CONTAGIOSUM; PHYSICIAN ATTITUDE; POXVIRUS; SEXUAL BEHAVIOR; VIRUS TRANSMISSION;

ADMINISTRATION, CUTANEOUS; AMINOQUINOLINES; HUMANS; KERATOLYTIC AGENTS; MOLLUSCUM CONTAGIOSUM; RANDOMIZED CONTROLLED TRIALS; TRETINOIN;

EID: 1842454324     PISSN: 00114162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Becker TM, Blount JH, Douglas J, et al. Trends in molluscum contagiosum in the United States, 1966-1983. Sex Transm Dis. 1986;13:88-92.
2. Gottlieb SL, Myskowski PL. Molluscum contagiosum. Int J Dermatol. 1994;33:453-461.
3. Baker B. Approach molluscum lesions with benign therapies first. Pediatric News. 1998;32:14.
4. Allen AL, Siegfried EC. Management of warts and molluscum in adolescents. Adolesc Med. 2001;12:vi, 229-242.
5. Silverberg NB, Sidbury R, Mancini AJ. Childhood molluscum contagiosum: experience with cantharidin therapy in 300 patients. J Am Acad Dermatol. 2000;43:503-507.
6. Drug Facts and Comparisons 1998. St. Louis, Mo: Facts & Comparisons; 1998.
7. Thomas JR III, Doyle JA. The therapeutic uses of topical vitamin A acid. J Am Acad Dermatol. 1981;4:505-513.
8. Romiti R, Ribeiro AP, Grinblat BM, et al. Treatment of molluscum contagiosum with potassium hydroxide: a clinical approach in 35 children. Pediatr Dermatol. 1999;16:228-231.
9. Kono T, Kondo S, Pastore S, et al. Effects of a novel topical immunomodulator, imiquimod, on keratinocyte cytokine gene expression. Lymphokine Cytokine Res. 1994;13:71-76.
10. Testerman TL, Gerster JF, Imbertson LM, et al. Cytokine induction by the immunomodulators imiquimod and S-27609. J Leukoc Biol. 1995;58:365-372.
11. Miller RL, Gerster JF, Owens ML, et al. Imiquimod applied topically: a novel immune response modifier and new class of drug. Int J Immunopharmacol. 1999;21:1-14.
12. Kende M, Lupton HW, Canonico PG. Treatment of experimental viral infections with immunomodulators. Adv Biosci. 1989;68:51-63.
13. Syed TA, Goswami J, Ahmadpour OA, et al. Treatment of molluscum contagiosum in males with an analog of imiquimod 1% in cream: a placebo-controlled, double-blind study. J Dermatol. 1998;25:309-313.
14. Barba AR, Kapoor S, Berman B. An open label safety study of topical imiquimod 5% cream in the treatment of molluscum contagiosum in children. Dermatol Online J. 2001;7:20. Available at: http://dermatology.cdlib.org/ DOJvol7num1/therapy /imiquimod/berman.html. Accessed December 17, 2002.
15. Hengge UR, Esser S, Schultewolter T, et al. Self-administered topical 5% imiquimod for the treatment of common warts and molluscum contagiosum. Br J Dermatol. 2000;143:1026-1031.